Mirum Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:MIRM) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 3.98 M-5.07 M-1.96 M12.04 M39.68 M6.07 M 55.83 M Cash from investing activities -18.04 M641 K-16.13 M-6.6 M-2.23 M1.01 M -23.95 M Cash from financing activities 3.86 M5.34 M6.36 M8.69 M16.1 M9 M 40.14 M Free cash flow -6.2 M-5.09 M-2 M11.91 M39.49 M5.47 M 54.87 M

Haberler

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Leerink, Mirum Pharmaceuticals hisse hedefini 118 dolara düşürdü

Evercore ISI, Mirum Pharmaceuticals için Outperform notunu korudu

Leerink cuts Mirum Pharmaceuticals stock price target to $118

Evercore ISI reiterates Mirum Pharmaceuticals stock rating at Outperform

Mirum Pharmaceuticals hisseleri Ar-Ge harcama görünümüyle düştü

Mirum Pharmaceuticals stock falls on R&D spending outlook, RBC reiterates Outperform

Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues

Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM)

Citizens, Mirum Pharmaceuticals için hisse fiyat hedefini düşürdü

Citizens cuts Mirum Pharmaceuticals stock price target on valuation

Mirum Pharmaceuticals kazancı $0,08 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek